During the past decade, Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo" #1 collaborator was "Janssen-Cilag S.p.A." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo" are "Chronic Myeloid Leukemia" (4 trials), "Leukemia" (2 trials), "Lymphoma" (2 trials), "ALL Ph Positive" (1 trials) and "AML" (1 trials). Many other conditions were trialed in "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo" in a lesser frequency.

Most popular intervention types in "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo" are "Drug" (19 trials), "Other" (4 trials), "Behavioral" (1 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (4 trials), "Rituximab" (4 trials), "Bendamustine" (2 trials), "Doxorubicin" (2 trials) and "Observation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo". 1 are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".